The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
crinecerfont · Capsule
6 marketed package NDCs · 1 active manufacturer
What changed in the last 90 days
Every detected change for crinecerfont, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- CrenessityAug 12, 2026Mfr exitedNeurocrine Biosciences, Inc. · crinecerfont
- CrenessityAug 12, 2026Mfr exitedNeurocrine Biosciences, Inc. · crinecerfont
- CrenessityAug 12, 2026Mfr exitedNeurocrine Biosciences, Inc. · crinecerfont
- CrenessityAug 12, 2026Mfr exitedNeurocrine Biosciences, Inc. · crinecerfont
Common questions
- Is Crinecerfont in shortage right now?
- No. FDA does not currently list Crinecerfont in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Crinecerfont?
- 2 companies have marketed Crinecerfont in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
Shortage reports for this molecule
- Planned discontinuation — Crenessity, Capsule, 25 mg (NDC 70370-5025-1)Apr 28, 2026
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.